| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 17518123 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 208 journal articles in the PubMed database | Email to a friend | | |
| Neumann ME
Managing anemia: what do we do now? [Journal Article]
Nephrol News Issues 2007 May; 21(6):50, 52.
Full Citation | Find Related Articles | | Spry L
The FDA, stocks, black boxes and ESAs. [Journal Article]
Nephrol News Issues 2007 May; 21(6):53-4.
Full Citation | Find Related Articles | | Traynor K
Reimbursement for erythropoiesis-stimulating agents poses challenges. [News]
Am J Health Syst Pharm 2008 Mar 1; 65(5):385-6.
Full Citation | Publisher Full Text | Find Related Articles | | Blaser R
Reaction from renal associations. Renal Physicians Association. [Journal Article]
Nephrol News Issues 2007 May; 21(6):61-2, 64.
Full Citation | Find Related Articles | | Steinbrook R
Erythropoietin, the FDA, and oncology. [Journal Article]
N Engl J Med 2007 Jun 14; 356(24):2448-51.
Full Citation | Publisher Full Text | Find Related Articles | | Singh AK
The FDA black box for EPO: what should nephrologists do? [Journal Article]
Nephrol News Issues 2007 May; 21(6):55-6, 58-9.
Full Citation | Find Related Articles | | Aapro MS, Birgegård G, Bokemeyer C, et al.
Erythropoietins should be used according to guidelines. [Comment, Letter]
Lancet Oncol 2008 May; 9(5):412-3.
Full Citation | Find Related Articles | | Sipkoff M
Rebates for anti-anemia drugs draw response from FDA, CMS. [Journal Article]
Manag Care 2007 Jun; 16(6):17-8.
Full Citation | Find Related Articles | | Steensma DP
New ASH/ASCO guidelines on the use of erythropoiesis-stimulating agents: a chorale amid cacophony. [Journal Article]
J Support Oncol 2007 Nov-Dec; 5(10):471-3.
Full Citation | Find Related Articles |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
